awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33588005-2F6E65F9-1CB8-44A4-9560-A28FE588D6E6
Q33588005-2F6E65F9-1CB8-44A4-9560-A28FE588D6E6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33588005-2F6E65F9-1CB8-44A4-9560-A28FE588D6E6
Diffusion-weighted MRI for assessment of early cancer treatment response.
P2860
Q33588005-2F6E65F9-1CB8-44A4-9560-A28FE588D6E6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33588005-2F6E65F9-1CB8-44A4-9560-A28FE588D6E6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f1891a36ede69965c46cfd557bb8eaaf8cca2e85
P2860
Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.